Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Sioux Nation -- Ignore unavailable to you. Want to Upgrade?

To: stockman_scott who wrote (54156)	1/7/2006 8:33:17 PM
From: Patricia Trinchero	Read Replies (2) \| Respond to of 362392

There are now companies that are doing clinical trials in India........ As someone who works in the research field I have to voice some concern over the entire issue. These trials should be completed under the strictest of standards and generally are done with that compliance level. Also, one can never be fully certain about various side effects until any drug has been used in thousands of people. It's financially impossible to conduct trials in that many individuals............our drugs are already too expensive. Releasing the drug into the general population is the best way to do a clinical trial but only after much safety and efficacy and Phase III large clinicals have been completed.